Article citationsMore>>

Tan, F., Gan, X., Deng, Y., Li, X., Guo, N., Hei, Z., et al. (2018) Intraoperative Dexmedetomidine Attenuates Postoperative Systemic Inflammatory Response Syndrome in Patients Who Underwent Percutaneous Nephrolithotomy: A Retrospective Cohort Study. Therapeutics and Clinical Risk Management, 14, 287-293.
https://doi.org/10.2147/tcrm.s157320

has been cited by the following article:

• TITLE: Research Progress on Early Diagnostic Markers of Urinary Tract Infection Complications after Percutaneous Nephrolithotomy

  AUTHORS: Yuchun Xu, Huawu Huang, Jiayu Mo, Liuxing Wei, Baode Lu

  KEYWORDS: Percutaneous Nephrolithotripsy, Urinary Sepsis, Biomarkers, Composite Index

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.13 No.1, January 21, 2025

  ABSTRACT: Urinary calculi are a common and frequently occurring disease in urology. For patients with kidney stones, especially large, multiple or staghorn stones, percutaneous nephrolithotomy (PCNL) is a preferred treatment method. Infection-related complications after percutaneous nephrolithotomy include transient fever, systemic inflammatory response syndrome, and urinary sepsis, especially urinary sepsis, which are considered to be common causes of death after percutaneous nephrolithotomy. Therefore, early identification and timely intervention of biomarkers can reduce the incidence and mortality of postoperative sepsis, as well as the length of hospital stay and hospitalization costs. This article reviews the biomarkers for early identification of urinary tract infection after PCNL, such as traditional inflammatory indicators, new inflammatory indicators, and composite inflammatory indicators.